ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$4.72
Tradestie Score
58
Market Cap
$35.25M
Analyst Upside
-78.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$7.70
|
$227.00M | - | 56 | Compare |
|
TRDA
Entrada Therapeutics, Inc. Common Stock
|
$6.83
|
$223.66M | - | 49 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.91
|
$211.28M | - | 59 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$4.88
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.79
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$24.44
|
$180.53M | - | 58 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$21.44
|
$170.45M | - | 60 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.94
|
$133.50M | - | 61 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.55
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.76
|
$110.20M | - | 53 | Compare |
More ANTX Analysis
Data updated: May 08, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry